EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Direct Single‐Dose Drug‐Provocation Test Is Safe for Delabelling Penicillin Low‐Risk Reactions in Adults

Marina Labella iD, Julia Rodriguez de Guzmán, Patricia Diez-Echave, María Salas iD, Rubén Fernández-Santamaría iD, Cristobalina Mayorga iD, Inmaculada Doña iD, María José Torres

Allergy · 2025

DOI: 10.1111/all.16567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2025. Verfasst von Marina Labella und 7 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Penicillins, Anti-Bacterial Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Institute of Health "Carlos III", Redes de Investigacion Cooperativa Orientadas al Resultado en Salud (RICORS): Enfermedades Inflamatorias, Andalusian Regional Ministry Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Penicillins (PENs) are the most frequent drug‐allergic reactions trigger. However, diagnostic work‐up is complex and time‐consuming: it requires skin testing (ST) and drug‐provocation test (DPT), needing faster delabelling strategies. Although direct DPT without previous STs has shown to be safe, most of the studies are performed in children or in North American, Asian, or Oceanian adults, with few studies in the European adult population. We explored its safety in European adult patients with low‐risk PEN allergy history and, additionally, analysed ST role and T‐cell involvement by lymphocyte transformation test (LTT).

Methods

We prospectively evaluated > 16 years of PEN‐allergic labelled patients referred to Málaga Regional University Hospital during 2023. They reported non‐immediate reactions without alarm signs and unknown reactions. Direct‐single‐dose DPT was performed in all patients. If positive, ST and LTT were carried out after reaction resolution.

Results

We included 269 patients with the culprits being an unidentified PEN (36%), amoxicillin (AX) (32%), and AX‐clavulanic acid (AX‐CLV) (31%); and the symptoms maculopapular exanthema (MPE) (34%) and unknown reaction during childhood (23%). Only 16 (5.9%) had positive DPT, being 56% for AX and 44% for AX‐CLV, 81% developing MPE, none severe. Most DPT‐reacting patients reported cutaneous non‐immediate reactions in the index reaction, and only one had an unknown childhood reaction. The mean day interval between drug administration and symptom development was lower ( p = 0.002) in positive DPT than in the index reaction (2 vs 5 days). Moreover, ST was positive in only 19% and LTTs in 86.7% of positive DPT patients.

Conclusions

Direct‐single‐dose DPT is safe for delabelling PEN allergy in non‐immediate reactions without alarm signs and unknown reactions. ST had a poor diagnostic value and LTT had a high one, confirming a T‐cell involvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug HypersensitivityPenicillinsAnti-Bacterial AgentsHumansMaleFemaleAdultMiddle AgedSkin TestsAgedProspective StudiesYoung AdultAdolescent

Stichwörter der Autor:innen

betalactamdelabellingdrug‐provocation testhypersensitivity reactionlymphocyte transformation testpenicillinsingle dose

Substanzen

PenicillinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
  • Allergy Research Group, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Málaga, Spain.
  • Departamento de Medicina, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
  • Nanostructures for Diagnosing and Treatment of Allergic Diseases Laboratory, Andalusian Center for Nanomedicine and Biotechnology-BIONAND, Málaga, Spain.

ORCID-Profile: Marina Labella, María Salas, Rubén Fernández-Santamaría, Cristobalina Mayorga, Inmaculada Doña

Förderung

  • Institute of Health "Carlos III"
  • Redes de Investigacion Cooperativa Orientadas al Resultado en Salud (RICORS): Enfermedades Inflamatorias
  • Andalusian Regional Ministry Health
  • Universidad de Málaga/ CBUA
  • Universidad de Málaga

Zitieren

APA

Labella, M., Rodriguez de Guzmán, J., Diez-Echave, P., Salas, M., Fernández-Santamaría, R., Mayorga, C., Doña, I., & Torres, M. J. (2025). Direct Single‐Dose Drug‐Provocation Test Is Safe for Delabelling Penicillin Low‐Risk Reactions in Adults. Allergy. https://doi.org/10.1111/all.16567

Vancouver

Labella M, Rodriguez de Guzmán J, Diez-Echave P, Salas M, Fernández-Santamaría R, Mayorga C, et al. Direct Single‐Dose Drug‐Provocation Test Is Safe for Delabelling Penicillin Low‐Risk Reactions in Adults. Allergy. 2025. doi:10.1111/all.16567

BibTeX
@article{Labella2025,
  author = {Labella, Marina and Rodriguez de Guzmán, Julia and Diez-Echave, Patricia and Salas, María and Fernández-Santamaría, Rubén and Mayorga, Cristobalina and Doña, Inmaculada and Torres, María José},
  title = {Direct Single‐Dose Drug‐Provocation Test Is Safe for Delabelling Penicillin Low‐Risk Reactions in Adults},
  journal = {Allergy},
  year = {2025},
  doi = {10.1111/all.16567}
}
Kostenlos starten →